Page last updated: 2024-08-24

liarozole and Dermatitis

liarozole has been researched along with Dermatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akira, S; Amiya, T; Fujisawa, K; Hashimoto, E; Kabashima, K; Kiyono, H; Kogure, Y; Kubo, M; Kunisawa, J; Kurashima, Y; Miyake, K; Otsuka, A; Sato, S; Sato, T; Shibata, N; Suzuki, Y	1

Other Studies

1 other study(ies) available for liarozole and Dermatitis

Article	Year
The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis. Immunity, 2014, Apr-17, Volume: 40, Issue:4 Topics: Adenosine Triphosphate; Animals; Cell Degranulation; Cytochrome P-450 Enzyme System; Dermatitis; Fibroblasts; Imidazoles; Immunity, Innate; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Receptors, Purinergic P2X7; Retinoic Acid 4-Hydroxylase; Skin; Toll-Like Receptor 2; Tretinoin	2014

Article

Year

The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis.

Immunity, 2014, Apr-17, Volume: 40, Issue:4

Topics: Adenosine Triphosphate; Animals; Cell Degranulation; Cytochrome P-450 Enzyme System; Dermatitis; Fibroblasts; Imidazoles; Immunity, Innate; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Receptors, Purinergic P2X7; Retinoic Acid 4-Hydroxylase; Skin; Toll-Like Receptor 2; Tretinoin

2014